CClinicalTrials.gg
Status unknownNCT04554823Updated Sep 18, 2020

Effects of a Physical Exercise and Health Education Program for Women With Breast Cancer Undergoing Chemotherapy

An interventional study of Health Education and Physical Exercise in Cancer, Breast, sponsored by Hospital Israelita Albert Einstein. Status unknown at 1 site in Brazil. Open to female participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2020-09-18.

Sponsored by Hospital Israelita Albert Einstein · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Sep 2020), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
136
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
Female
01

Study summary

The purpose of this study is to verify the effect of the intervention of a program of physical exercises and health education in women with breast cancer undergoing chemotherapy.

Read the detailed description

According to the National Cancer Institute (INCA), the estimate for Brazil, 2016-2017 biennium, points to the occurrence of about 600,000 new cases of cancer, and breast cancer (58000) in women will be the most frequent. One study revealed that only 12% of women undergoing chemotherapy in CM who participated in a physical exercise program had to readjusted the dose of the medications, while 34% of those who received the conventional treatment needed to readjust the Treatment doses, with neuropathy being one of the most present adverse effects that influenced this adjustment. In this sense, the conduct to keep the patient at rest during the treatment seems to potentiate her side effects, and sedentarism is another factor detrimental to the patient's health. Objective: To verify the effect of the intervention of a program of physical exercises and health education in women with breast cancer undergoing chemotherapy. Methodology: A sample will consist of 136 (136) Women, over 18 years of age, sedentary, diagnosed with non-metastatic breast cancer and initiating the first cycle of chemotherapy. They will be divided into two groups, randomly and stratified: control group: (CG n = 68) and exercise group: (eg n = 68) that will undergo a supervised training program of combined exercises for 24 weeks, with a frequency of 3 times Weekly and duration of 60 minutes, an unsupervised flexibility training program 2 times a week and both groups (GC and EG) will attend lectures on health education, which are held monthly.

02

Conditions studied

  • Cancer, Breast

Browse trials for

Keywords

  • Cancer
  • Physical Exercise
  • Health Education Program
03

In context

Breast Neoplasms

12,544 studies on the registry are indexed under Breast Neoplasms; 2,892 are open to participants now.

This study's planned enrollment of 136 is above the median of 72 across 9,303 interventional studies indexed under Breast Neoplasms.

Browse Breast Neoplasms studies →

Lead sponsor

Hospital Israelita Albert Einstein is the lead sponsor of 143 studies on the registry; 32 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • women over 18 years of age;
  • with the first diagnosis of non-metastatic breast cancer;
  • Sedentary for 6 months;
  • who are in the initial cycle of chemotherapy;
  • with the release of the responsible physician;
  • availability to participate in the exercise program;
  • signing of the free and clarified consent term.

Exclusion criteria

Exclusion Criteria:

  • women with clinical risk for physical exercise (e.g. severe anemia, ICC, CRI);
  • Pregnant women;
  • Osteoarticular problems that preclude the practice of physical exercise.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
136 participants (estimated)

Study arms

  • Placebo comparator
    Control Group

    Will attend lectures on health education.

    Behavioral: Health Education · Behavioral: Physical Exercise

  • Experimental
    Exercise Group

    Will be subjected to a supervised training program of combined exercises for 24 weeks, with a frequency of 3 times weekly and duration of 60 minutes, an unsupervised flexibility training program 2 times a week and Will attend lectures on health education.

    Behavioral: Health Education · Behavioral: Physical Exercise

Interventions

  • BehavioralHealth Education

    Will attend lectures on health education about Health and Physical Education, healthy eating, overcoming barriers, Back to routine, Physical Activity Options and Dealing with Stress and Depression

  • BehavioralPhysical Exercise

    Supervised physical training program of combined exercises for 24 weeks, with frequency of 3 times weekly and duration of 60 minutes, an unsupervised flexibility training program 2 times a week.

06

What researchers measure

Primary outcomes

  1. Chemotherapy completion rate

    Effect of physical training on the rate of chemotherapy completion in the anthropometric profile, habitual food consumption, prevalence of comorbidities, cardiovascular, neurofunctional, bone and respiratory toxicity, myelosuppression, sarcopenia induced by chemotherapy, myalgia, nausea and vomiting symptoms.

    Time frame: 6 months

  2. Analysis of the level of Quality of Life

    effect of physical training on the level of physical activity, perception of fatigue and pain, mood, sexual life, anxiety and depression and body image.

    Time frame: 6 months

  3. Physical aptitude

    Effect of physical training during adjuvant and neoadjuvant chemotherapy on the levels of fragility, muscle strength, joint amplitude of the shoulder and cardiorespiratory capacity.

    Time frame: 6 months

07

Study locations

1 site
  • Hospital Municipal Vila Santa Catarina
    São Paulo, 04378500, Brazil
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 18, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04554823
Lead sponsor
Hospital Israelita Albert Einstein
Responsible party
Sponsor
First posted
Sep 18, 2020
Start date
Mar 1, 2019
Primary completion
Sep 13, 2020
Completion
Jan 31, 2023 (estimated)
Last update
Sep 18, 2020

Study contacts

Mayra Trevisani
study chair · External Researcher
Luana Queiroga
study chair · Employee

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion